NeurAxis, Inc.

General ticker "NRXS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $73.6M (TTM average)

NeurAxis, Inc. follows the US Stock Market performance with the rate: 41.8%.

Estimated limits based on current volatility of 7.1%: low 4.61$, high 5.31$

Factors to consider:

  • Total employees count: 24 (+14.3%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Regulatory and compliance, Commercialization delays, Market acceptance, Market competition, Supply chain disruptions
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.42$, 5.82$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.03$, 5.00$]

Financial Metrics affecting the NRXS estimates:

  • Positive: with PPE of -4.3 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Negative: negative Net income
  • Negative: negative Industry operating cash flow (median)
  • Negative: Inventory ratio change, % of 5.58 > 4.15
  • Positive: Interest expense per share per price, % of 0.20 <= 0.49
  • Negative: -0.26 < Industry inventory ratio change (median), % of 0

Similar symbols

Short-term NRXS quotes

Long-term NRXS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $2.46MM $2.69MM $3.57MM
Operating Expenses $9.12MM $9.84MM $11.40MM
Operating Income $-6.66MM $-7.16MM $-7.83MM
Non-Operating Income $-7.96MM $-1.08MM $0.03MM
Interest Expense $0.48MM $0.17MM $0.07MM
R&D Expense $0.17MM $0.21MM $0.49MM
Income(Loss) $-14.63MM $-8.24MM $-7.80MM
Net Income(Loss)* $-14.63MM $-8.24MM $-7.80MM
Stockholders Equity $-1.40MM $2.07MM $3.40MM
Inventory $0.02MM $0.04MM $0.26MM
Assets $0.51MM $4.76MM $6.40MM
Operating Cash Flow $-6.69MM $-6.10MM $-6.43MM
Capital expenditure $0.07MM $0.03MM $0.03MM
Investing Cash Flow $-0.07MM $-0.03MM $-0.13MM
Financing Cash Flow $6.59MM $9.74MM $7.83MM
Earnings Per Share** $-2.32 $-1.19 $-0.86

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.